JIANGSU HANSOH PHARM FDA Approval ANDA 209399

ANDA 209399

JIANGSU HANSOH PHARM

FDA Drug Application

Application #209399

Application Sponsors

ANDA 209399JIANGSU HANSOH PHARM

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001TABLET;ORAL2.5MG0OLANZAPINEOLANZAPINE
002TABLET;ORAL5MG0OLANZAPINEOLANZAPINE
003TABLET;ORAL10MG0OLANZAPINEOLANZAPINE

FDA Submissions

UNKNOWN; ORIG1AP2018-09-24STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB

CDER Filings

JIANGSU HANSOH PHARM
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 209399
            [companyName] => JIANGSU HANSOH PHARM
            [docInserts] => ["",""]
            [products] => [{"drugName":"OLANZAPINE","activeIngredients":"OLANZAPINE","strength":"2.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"OLANZAPINE","activeIngredients":"OLANZAPINE","strength":"5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"OLANZAPINE","activeIngredients":"OLANZAPINE","strength":"10MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"09\/24\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-09-24
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.